Mousa SA - Search Results

1

Characterization of tryptophan-containing dipeptides for anti-angiogenic effects.

Khedr S, Klotzsche-von Ameln A, Khedr M, Elsayed MH, Sudha T, Mousa SA, Deussen A, Martin M. Khedr S, et al. Among authors: mousa sa. Acta Physiol (Oxf). 2021 Feb;231(2):e13556. doi: 10.1111/apha.13556. Epub 2020 Sep 15. Acta Physiol (Oxf). 2021. PMID: 32894635

2

Anti-angiogenic mechanisms and efficacy of the low molecular weight heparin, tinzaparin: anti-cancer efficacy.

Mousa SA, Mohamed S. Mousa SA, et al. Oncol Rep. 2004 Oct;12(4):683-8. Oncol Rep. 2004. PMID: 15375485

3

Stress resistant human embryonic stem cells as a potential source for the identification of novel cancer stem cell markers.

Mousa SA, Sudha T, Dyskin E, Dier U, Gallati C, Hanko C, Chittur SV, Rebbaa A. Mousa SA, et al. Cancer Lett. 2010 Mar 28;289(2):208-16. doi: 10.1016/j.canlet.2009.08.018. Epub 2009 Sep 4. Cancer Lett. 2010. PMID: 19733430

4

The anti-angiogenic activity of NSITC, a specific cathepsin L inhibitor.

Rebbaa A, Chu F, Sudha T, Gallati C, Dier U, Dyskin E, Yalcin M, Bianchini C, Shaker O, Mousa SA. Rebbaa A, et al. Among authors: mousa sa. Anticancer Res. 2009 Nov;29(11):4473-81. Anticancer Res. 2009. Retraction in: Anticancer Res. 2023 Oct;43(10):4780. doi: 10.21873/anticanres.16674 PMID: 20032394 Free article. Retracted.

5

Inhibitory effect of non-anticoagulant heparin (S-NACH) on pancreatic cancer cell adhesion and metastasis in human umbilical cord vessel segment and in mouse model.

Sudha T, Phillips P, Kanaan C, Linhardt RJ, Borsig L, Mousa SA. Sudha T, et al. Among authors: mousa sa. Clin Exp Metastasis. 2012 Jun;29(5):431-9. doi: 10.1007/s10585-012-9461-9. Epub 2012 Mar 14. Clin Exp Metastasis. 2012. PMID: 22415710

6

Nano chitosan peptide as a potential therapeutic carrier for retinal delivery to treat age-related macular degeneration.

Jayaraman MS, Bharali DJ, Sudha T, Mousa SA. Jayaraman MS, et al. Among authors: mousa sa. Mol Vis. 2012;18:2300-8. Epub 2012 Sep 3. Mol Vis. 2012. PMID: 22977298 Free PMC article.

7

OT-404, multi-targeted anti-cancer agent affecting tumor proliferation, chemo-resistance, and angiogenesis.

Rebbaa A, Patil G, Yalcin M, Sudha T, Mousa SA. Rebbaa A, et al. Among authors: mousa sa. Cancer Lett. 2013 May 10;332(1):55-62. doi: 10.1016/j.canlet.2013.01.016. Epub 2013 Jan 21. Cancer Lett. 2013. PMID: 23348692

8

Response of human pancreatic cancer cell xenografts to tetraiodothyroacetic acid nanoparticles.

Yalcin M, Lin HY, Sudha T, Bharali DJ, Meng R, Tang HY, Davis FB, Stain SC, Davis PJ, Mousa SA. Yalcin M, et al. Among authors: mousa sa. Horm Cancer. 2013 Jun;4(3):176-85. doi: 10.1007/s12672-013-0137-y. Epub 2013 Feb 28. Horm Cancer. 2013. PMID: 23456390 Free PMC article.

9

Suppression of pancreatic cancer by sulfated non-anticoagulant low molecular weight heparin.

Sudha T, Yalcin M, Lin HY, Elmetwally AM, Nazeer T, Arumugam T, Phillips P, Mousa SA. Sudha T, et al. Among authors: mousa sa. Cancer Lett. 2014 Aug 1;350(1-2):25-33. doi: 10.1016/j.canlet.2014.04.016. Epub 2014 Apr 24. Cancer Lett. 2014. PMID: 24769074 Free PMC article.

10

Nanotetrac targets integrin αvβ3 on tumor cells to disorder cell defense pathways and block angiogenesis.

Davis PJ, Lin HY, Sudha T, Yalcin M, Tang HY, Hercbergs A, Leith JT, Luidens MK, Ashur-Fabian O, Incerpi S, Mousa SA. Davis PJ, et al. Among authors: mousa sa. Onco Targets Ther. 2014 Sep 18;7:1619-24. doi: 10.2147/OTT.S67393. eCollection 2014. Onco Targets Ther. 2014. PMID: 25258542 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

676 results

Search Page

Filters